Thompson, Siegel, & Walmsley »

Biosante Pharmaceuticals shares owned by Thompson, Siegel, & Walmsley

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Thompson, Siegel, & Walmsley from 13F filings

Historical chart of Thompson, Siegel, & Walmsley investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Thompson, Siegel, & Walmsley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Thompson, Siegel, & Walmsley

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 213k 55.14
2023-09-30 $13M 229k 58.06
2023-06-30 $20M 362k 53.83
2023-03-31 $16M 394k 39.72
2022-12-31 $17M 415k 40.23
2022-09-30 $13M 416k 32.14
2022-06-30 $13M 436k 29.67
2022-03-31 $12M 424k 28.11
2021-12-31 $13M 280k 46.08
2021-09-30 $15M 451k 32.82
2021-06-30 $13M 381k 35.05
2021-03-31 $12M 329k 36.14
2020-12-31 $9.7M 333k 29.04
2020-09-30 $9.5M 337k 28.21
2020-06-30 $9.7M 299k 32.34
2020-03-31 $161k 3.9k 40.84